Moreover, Andriani et al. [10] have reported that defects in the immune function of patients with sepsis are associated with high PD-1 or PD-L1 expression and can be restored by treatment with antibodies targeting PD-1 or PD-L1. The gene discussed is PDCD1; the disease is Sepsis.